09.12.2009 • News

Huntsman Posts Loss

Huntsman posted a wider-than-expected quarterly loss, hurt by decreased demand in all of its businesses. Net loss for the Q1 was $290 million compared with net income of $7 million a year earlier. Revenue fell 33 % to $1.69 billion and missed analysts' average forecast of $2.17 billion. Huntsman, which recently terminated a $6.5 billion pact to be acquired by Apollo Management's Hexion Specialty Chemicals, said it intends to reduce its full-time workforce by about 1,250 positions, or nearly 10 %.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

most read